Anti-GDIR3/ ARHGDIG/ RHOGDI-3 monoclonal antibody

Anti-GDIR3/ ARHGDIG/ RHOGDI-3 antibody for FACS & in-vivo assay

Target products collectionGo to ARHGDIG/ARHGDIG products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2000-Ab-1/ GM-Tg-hg-MP2000-Ab-2Anti-Human ARHGDIG monoclonal antibodyHuman
GM-Tg-rg-MP2000-Ab-1/ GM-Tg-rg-MP2000-Ab-2Anti-Rat ARHGDIG monoclonal antibodyRat
GM-Tg-mg-MP2000-Ab-1/ GM-Tg-mg-MP2000-Ab-2Anti-Mouse ARHGDIG monoclonal antibodyMouse
GM-Tg-cynog-MP2000-Ab-1/ GM-Tg-cynog-MP2000-Ab-2Anti-Cynomolgus/ Rhesus macaque ARHGDIG monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2000-Ab-1/ GM-Tg-felg-MP2000-Ab-2Anti-Feline ARHGDIG monoclonal antibodyFeline
GM-Tg-cang-MP2000-Ab-1/ GM-Tg-cang-MP2000-Ab-2Anti-Canine ARHGDIG monoclonal antibodyCanine
GM-Tg-bovg-MP2000-Ab-1/ GM-Tg-bovg-MP2000-Ab-2Anti-Bovine ARHGDIG monoclonal antibodyBovine
GM-Tg-equg-MP2000-Ab-1/ GM-Tg-equg-MP2000-Ab-2Anti-Equine ARHGDIG monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2000-Ab-1/ GM-Tg-hg-MP2000-Ab-2; GM-Tg-rg-MP2000-Ab-1/ GM-Tg-rg-MP2000-Ab-2;
GM-Tg-mg-MP2000-Ab-1/ GM-Tg-mg-MP2000-Ab-2; GM-Tg-cynog-MP2000-Ab-1/ GM-Tg-cynog-MP2000-Ab-2;
GM-Tg-felg-MP2000-Ab-1/ GM-Tg-felg-MP2000-Ab-2; GM-Tg-cang-MP2000-Ab-1/ GM-Tg-cang-MP2000-Ab-2;
GM-Tg-bovg-MP2000-Ab-1/ GM-Tg-bovg-MP2000-Ab-2; GM-Tg-equg-MP2000-Ab-1/ GM-Tg-equg-MP2000-Ab-2
Products NameAnti-ARHGDIG monoclonal antibody
Formatmab
Target NameARHGDIG
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ARHGDIG benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GDIR3/ ARHGDIG/ RHOGDI-3 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP000011human ARHGDIG Lentivirus plasmid
    ORF Viral VectorvGMLP000011human ARHGDIG Lentivirus particle
    ORF Viral VectorpGMLPm004510mouse Arhgdig Lentivirus plasmid
    ORF Viral VectorvGMLPm004510mouse Arhgdig Lentivirus particle


    Target information

    Target IDGM-MP2000
    Target NameARHGDIG
    Gene ID398,14570,360500,722292,611541,101096279,613745,100146456
    Gene Symbol and SynonymsARHGDIG,Gdi5,Rho-GDI-3,Rho-GDI2,RHOGDI-3,RIP2
    Uniprot AccessionQ99819,Q0II80
    Uniprot Entry NameGDIR3_HUMAN,GDIR3_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000242173
    Target ClassificationN/A

    The target: ARHGDIG, gene name: ARHGDIG, also named as RHOGDI-3. The GDP-dissociation inhibitors (GDIs) play a primary role in modulating the activation of GTPases by inhibiting the exchange of GDP for GTP. See ARHGDIB (MIM 602843).[supplied by OMIM, Nov 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.